FDA/Cryogen Labeling Dispute Attracts Congressional Interest
This article was originally published in The Gray Sheet
Executive Summary
The House Commerce Committee has asked FDA Commissioner Jane Henney to review the agency's decision requiring Cryogen to submit a premarket approval application to expand the labeling of its First Option intrauterine cryosurgical probe to include specific references to endometrial ablation.